0

Global Tyrosine Kinase Inhibitors Market 2019-2023

  • Published: Dec 2018
  • Pages: 122
  • SKU: IRTNTR30518
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global tyrosine kinase inhibitors market size will grow by USD 24.58 billion during 2019-2023. This report offers an analysis of the market based on product (RTKIs and nRTKIs) and geography (the Americas, APAC, and EMEA). The report analyzes the market’s competitive landscape and offers information on several companies including Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, Novartis, and Pfizer.

Below are some of the key findings from the tyrosine kinase inhibitors market research report

Tyrosine Kinase Inhibitors Market

 

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global tyrosine kinase inhibitors industry overview

A key factor driving the growth of the global tyrosine kinase inhibitors market is the growing prevalence of cancers and ophthalmic diseases. With factors such as unhealthy lifestyle, genetic mutations, obesity, and environmental changes, there has been an increase in the prevalence of various types of cancers and ophthalmic diseases such as retinal vein occlusion (RVO) worldwide. Medical conditions such as hypertension, diabetes, and open-angle glaucoma are the high-risk factors for RVO. The high prevalence of various types of cancers and RVO will stimulate the growth of the global TKIs market during the forecast period.

The expansion of research areas of TKIs is identified as one of the key emerging trends in the global tyrosine kinase inhibitors market. As tyrosine kinase inhibitors have demonstrated efficacy in various oncology indications, several companies are focusing on expanding their clinical reach. With the aim to improve the treatment of various types of cancers, there are over 1000 clinical trials that are being carried out by various companies and two combination therapies were recently approved. Such an expansion in the research areas of TKIs will have a substantial impact on the global TKIs market during the forecast period. Apart from the growing prevalence of cancers and ophthalmic diseases, factors such as the high target affinity and specificity of TKIs, and the recent approvals of TKIs are expected to trigger the market to grow at a CAGR of over 8% during the forecast period

Top tyrosine kinase inhibitors companies covered in this market research report

The tyrosine kinase inhibitors market is moderately fragmented. These players are leveraging advanced technologies to offer high-quality products to meet the evolving needs of the end-user industries. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this tyrosine kinase inhibitors industry analysis report will aid clients to identify new growth opportunities and design new growth strategies.

The report offers a complete analysis of various companies including:

  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Novartis
  • Pfizer

Tyrosine kinase inhibitors market segmentation based on geographic regions

  • Americas
  • APAC
  • EMEA

With a complete study of the growth opportunities for the companies, the Americas will account for the highest growth of this market throughout the forecast period. The high prevalence rate of chronic metabolic diseases and several types of cancer in Canada and the US is one of the primary reasons for the high growth of the tyrosine kinase inhibitors market in this region.

Tyrosine kinase inhibitors market segmentation based on product

  • RTKIs
  • nRTKIs

The RTKIs segment will account for the highest growth in the market due to the high target affinity of drugs that are approved and in the market. Additionally, the report also provides an accurate prediction of the contribution of the various products segments to the growth of the tyrosine kinase inhibitors market size.

Key highlights of the global tyrosine kinase inhibitors market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the tyrosine kinase inhibitors market during the next five years
  • Precise estimation of the global tyrosine kinase inhibitors market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the tyrosine kinase inhibitors industry across the Americas, APAC, and EMEA
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on the factors that will challenge the growth of tyrosine kinase inhibitors companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • The threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • RTKIs - Market size and forecast 2018-2023
  • nRTKIs - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Novartis
  • Pfizer

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>